
Proceedings Paper
Opto-acoustic image fusion technology for diagnostic breast imaging in a feasibility studyFormat | Member Price | Non-Member Price |
---|---|---|
$17.00 | $21.00 |
Paper Abstract
Functional opto-acoustic (OA) imaging was fused with gray-scale ultrasound acquired using a specialized duplex handheld probe. Feasibility Study findings indicated the potential to more accurately characterize breast masses for cancer than conventional diagnostic ultrasound (CDU). The Feasibility Study included OA imagery of 74 breast masses that were collected using the investigational Imagio® breast imaging system. Superior specificity and equal sensitivity to CDU was demonstrated, suggesting that OA fusion imaging may potentially obviate the need for negative biopsies without missing cancers in a certain percentage of breast masses. Preliminary results from a 100 subject Pilot Study are also discussed. A larger Pivotal Study (n=2,097 subjects) is underway to confirm the Feasibility Study and Pilot Study findings.
Paper Details
Date Published: 17 March 2015
PDF: 6 pages
Proc. SPIE 9419, Medical Imaging 2015: Ultrasonic Imaging and Tomography, 941909 (17 March 2015); doi: 10.1117/12.2081679
Published in SPIE Proceedings Vol. 9419:
Medical Imaging 2015: Ultrasonic Imaging and Tomography
Johan G. Bosch; Neb Duric, Editor(s)
PDF: 6 pages
Proc. SPIE 9419, Medical Imaging 2015: Ultrasonic Imaging and Tomography, 941909 (17 March 2015); doi: 10.1117/12.2081679
Show Author Affiliations
Jason Zalev, Seno Medical Instruments, Inc. (United States)
Bryan Clingman, Seno Medical Instruments, Inc. (United States)
Don Herzog, Seno Medical Instruments, Inc. (United States)
Tom Miller, Seno Medical Instruments, Inc. (United States)
Michael Ulissey M.D., Seno Medical Instruments, Inc. (United States)
A. Thomas Stavros M.D., Seno Medical Instruments, Inc. (United States)
Bryan Clingman, Seno Medical Instruments, Inc. (United States)
Don Herzog, Seno Medical Instruments, Inc. (United States)
Tom Miller, Seno Medical Instruments, Inc. (United States)
Michael Ulissey M.D., Seno Medical Instruments, Inc. (United States)
A. Thomas Stavros M.D., Seno Medical Instruments, Inc. (United States)
Alexander Oraevsky, TomoWave Laboratories, Inc. (United States)
Philip Lavin, Boston Biostatistics Research Foundation (United States)
Kenneth Kist M.D., The Univ. of Texas Health Science Ctr. (United States)
N. Carol Dornbluth M.D., The Univ. of Texas Health Science Ctr. (United States)
Pamela Otto M.D., The Univ. of Texas Health Science Ctr. (United States)
Philip Lavin, Boston Biostatistics Research Foundation (United States)
Kenneth Kist M.D., The Univ. of Texas Health Science Ctr. (United States)
N. Carol Dornbluth M.D., The Univ. of Texas Health Science Ctr. (United States)
Pamela Otto M.D., The Univ. of Texas Health Science Ctr. (United States)
Published in SPIE Proceedings Vol. 9419:
Medical Imaging 2015: Ultrasonic Imaging and Tomography
Johan G. Bosch; Neb Duric, Editor(s)
© SPIE. Terms of Use
